Synthomer PLC (GB:SYNT)
LSE:SYNT
Want to see GB:SYNT full AI Analyst Report?
Top Page
Synthomer
(LSE:SYNT)
Select Model
Select Model
Rating:49Neutral
Price Target:
99.00 p
▲(75.84% Upside)
Action:Reiterated
Date:05/06/26
The score is held back primarily by weak financial performance, with sustained losses and inconsistent revenue trends despite improved leverage and a 2025 cash flow rebound. Technicals are supportive due to a strong uptrend and positive momentum, but the very high RSI suggests overextended conditions. Valuation is also challenged by loss-making results (negative P/E) and no dividend yield data.
Positive Factors
Deleveraging
Sharp reduction in total debt by 2025 materially lowers interest and refinancing risk, giving management greater strategic flexibility. Durable deleveraging improves resilience to cyclical end-market downturns and frees capacity for targeted investment or restructuring over the next 2–6 months and beyond.
Negative Factors
Sustained Losses
Multi-year operating losses reduce reinvestment capacity, constrain strategic options and raise execution risk. Persistent negative operating profit undermines margin recovery prospects and means any turnaround depends on durable improvements in pricing, mix and cost control rather than short-term fixes.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraging
Sharp reduction in total debt by 2025 materially lowers interest and refinancing risk, giving management greater strategic flexibility. Durable deleveraging improves resilience to cyclical end-market downturns and frees capacity for targeted investment or restructuring over the next 2–6 months and beyond.
Read all positive factors
Synthomer (SYNT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£162.30M
Dividend YieldN/A
Average Volume (3M)1.10M
Price to Earnings (P/E)―
Beta (1Y)1.52
Revenue Growth-12.46%
EPS Growth-116.21%
CountryUK
Employees4,000
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.92
Shares Outstanding163,997,630
10 Day Avg. Volume933,327
30 Day Avg. Volume1,097,050
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.11
Price to Sales (P/S)0.06
P/FCF Ratio2.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£82.50Price Target Upside46.54% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)£1.86B
Synthomer Business Overview & Revenue Model
Company Description
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic poly...
How the Company Makes Money
Synthomer makes money primarily by manufacturing and selling specialty polymer products (notably emulsions/latices and other performance polymers) to industrial customers, generating revenue from product sales under supply agreements and spot/cont...
Synthomer Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
54
Neutral
Cash Flow
49
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.74B | 1.99B | 1.97B | 2.33B | 2.14B |
| Gross Profit | 167.40M | 337.70M | 307.30M | 281.00M | 569.70M |
| EBITDA | 137.00M | 83.00M | 113.40M | 139.40M | 394.40M |
| Net Income | -157.00M | -72.60M | -67.00M | -32.50M | 208.70M |
Balance Sheet | |||||
| Total Assets | 2.28B | 2.54B | 2.71B | 3.15B | 2.55B |
| Cash, Cash Equivalents and Short-Term Investments | 189.90M | 225.80M | 371.30M | 227.70M | 505.30M |
| Total Debt | 818.50M | 878.70M | 926.30M | 1.30B | 663.00M |
| Total Liabilities | 1.37B | 1.43B | 1.54B | 2.11B | 1.52B |
| Stockholders Equity | 900.80M | 1.09B | 1.15B | 1.02B | 1.02B |
Cash Flow | |||||
| Free Cash Flow | 36.60M | -124.10M | 66.00M | 45.00M | 193.20M |
| Operating Cash Flow | 124.30M | -33.50M | 150.00M | 135.80M | 275.40M |
| Investing Cash Flow | -65.00M | -61.70M | 107.70M | -850.10M | -78.60M |
| Financing Cash Flow | -96.80M | -45.90M | -90.90M | 414.50M | 118.50M |
Synthomer Technical Analysis
Positive
56.30
Price Trends
53.91
Positive
49.54
Positive
55.04
Positive
Market Momentum
15.41
Negative
65.27
Neutral
49.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SYNT, the sentiment is Positive. The current price of 56.3 is below the 20-day moving average (MA) of 82.32, above the 50-day MA of 53.91, and above the 200-day MA of 55.04, indicating a bullish trend. The MACD of 15.41 indicates Negative momentum. The RSI at 65.27 is Neutral, neither overbought nor oversold. The STOCH value of 49.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:SYNT.
Synthomer Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £531.16M | -3.84 | -4.95% | 9.48% | -1.24% | -166.15% | |
70 Outperform | £188.12M | 8.69 | 18.25% | 2.00% | 7.24% | ― | |
66 Neutral | £3.95B | 1,203.12 | 2.82% | 3.45% | 4.38% | -60.87% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | £842.88M | 16.15 | -6.85% | 1.34% | -21.51% | 7.34% | |
49 Neutral | £162.30M | -0.66 | -16.66% | ― | -12.46% | -116.21% | |
46 Neutral | £248.13M | 38.33 | 0.79% | 2.44% | -0.13% | -82.00% |
* Basic Materials Sector Average
GB:SYNT
Synthomer
99.00
-0.80
-0.80%
GB:CRDA
Croda International
2,827.00
-158.21
-5.30%
GB:ELM
Elementis
147.20
20.67
16.33%
GB:ESNT
Essentra
87.40
-10.74
-10.94%
GB:VCT
Victrex
610.00
-112.16
-15.53%
GB:ZTF
Zotefoams
382.50
113.83
42.37%
Synthomer Corporate Events
Delistings and Listing ChangesRegulatory Filings and Compliance
Synthomer Adds 430,000 Fully Fungible Shares to LSE Listing
Neutral
May 8, 2026
Synthomer plc has increased its issued share capital through the admission of 430,008 additional ordinary shares to trading on the London Stock Exchange’s Main Market. Following this admission on 8 May 2026, the company’s total number ...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Synthomer Issues New Shares to Lenders as Part of Debt Refinancing
Neutral
May 7, 2026
Synthomer has issued 430,008 new ordinary shares, equivalent to about 0.26% of its enlarged share capital, to certain lenders as payment for fees linked to the recent refinancing of its key debt facilities and following the publication of its 2025...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Synthomer files 2025 annual report and sets date for 2026 AGM
Neutral
Apr 30, 2026
Synthomer has published its annual report and accounts for the year ended 31 December 2025 and has submitted the document to the U.K. National Storage Mechanism in line with listing obligations. The report is available on the company’s websi...
Executive/Board Changes
Synthomer CFO Defers Part of 2025 Bonus Into Company Shares
Positive
Apr 30, 2026
Synthomer disclosed that its chief financial officer, Lily Liu, has deferred part of her 2025 annual cash bonus into ordinary shares of the company, aligning a portion of her remuneration more closely with shareholder returns. The transaction, exe...
Business Operations and StrategyExecutive/Board Changes
Synthomer CEO Defers 2025 Bonus Into Company Shares
Positive
Apr 30, 2026
Synthomer has disclosed that Chief Executive Officer Michael Willome has deferred part of his 2025 annual cash bonus into ordinary shares of the company. The transaction, executed on the London Stock Exchange on 30 April 2026, involved the acquisi...
Business Operations and StrategyExecutive/Board Changes
Synthomer appoints interim CFO as Lily Liu departs for Umicore
Neutral
Apr 30, 2026
Synthomer has announced a leadership transition in its finance function, with Chief Financial Officer and Executive Director Lily Liu set to leave at the end of May to become CFO of Belgian materials and recycling group Umicore. Liu, who joined in...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Synthomer Lifts Margins and Cash Flow as It Refocuses on Speciality Polymers
Positive
Apr 30, 2026
Synthomer reported 2025 results in line with expectations, with revenue down 10% on weaker end‑market demand but further margin gains from cost savings and portfolio mix, and resilient EBITDA of £136.5m. Strong free cash flow turned pos...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Synthomer Reconfirms 2025 Performance and Advances Debt Refinancing Plan
Positive
Mar 19, 2026
Synthomer reconfirmed its 2025 guidance, with continuing revenue of about £1.74bn, EBITDA between £135m and £138m, improved margins and positive free cash flow supported by expanded cost‑reduction measures. The group reported ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.